Cited 66 times in
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박준용 | - |
dc.contributor.author | 이현웅 | - |
dc.date.accessioned | 2020-12-01T17:42:43Z | - |
dc.date.available | 2020-12-01T17:42:43Z | - |
dc.date.issued | 2020-10 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/180396 | - |
dc.description.abstract | Clinical practice guidelines are important for guiding the management of specific diseases by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as a reference for health policymakers in controlling diseases with a large public impact. With this in mind, practice guidelines for the management of chronic hepatitis B (CHB) have been developed in the United States, Europe, and Asian-Pacific regions to suggest the best-fit recommendations for each social and medical circumstance. Recently, the Korean Association for the Study of the Liver published a revised version of its clinical practice guidelines for the management of CHB. The guidelines included updated information based on newly available antiviral agents, the most recent opinion on the initiation and cessation of treatment, and updates for the management of drug resistance, partial virological response, and side effects. Additionally, CHB management in specific situations was comprehensively revised. This review compares the similarities and differences among the various practice guidelines to identify unmet needs and improve future recommendations. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Korean Association for the Study of the Liver | - |
dc.relation.isPartOf | CLINICAL AND MOLECULAR HEPATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Hyung Joon Yim | - |
dc.contributor.googleauthor | Ji Hoon Kim | - |
dc.contributor.googleauthor | Jun Yong Park | - |
dc.contributor.googleauthor | Eileen L Yoon | - |
dc.contributor.googleauthor | Hana Park | - |
dc.contributor.googleauthor | Jung Hyun Kwon | - |
dc.contributor.googleauthor | Dong Hyun Sinn | - |
dc.contributor.googleauthor | Sae Hwan Lee | - |
dc.contributor.googleauthor | Jeong-Hoon Lee | - |
dc.contributor.googleauthor | Hyun Woong Lee | - |
dc.identifier.doi | 10.3350/cmh.2020.0049 | - |
dc.contributor.localId | A01675 | - |
dc.contributor.localId | A03292 | - |
dc.relation.journalcode | J00557 | - |
dc.identifier.eissn | 2287-285X | - |
dc.identifier.pmid | 32854458 | - |
dc.subject.keyword | Clinical practice guidelines | - |
dc.subject.keyword | Hepatitis B virus | - |
dc.subject.keyword | Hepatitis B, Chronic | - |
dc.contributor.alternativeName | Park, Jun Yong | - |
dc.contributor.affiliatedAuthor | 박준용 | - |
dc.contributor.affiliatedAuthor | 이현웅 | - |
dc.citation.volume | 26 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 411 | - |
dc.citation.endPage | 429 | - |
dc.identifier.bibliographicCitation | CLINICAL AND MOLECULAR HEPATOLOGY, Vol.26(4) : 411-429, 2020-10 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.